KEGG  Gastric cancer - Reference pathway

Scale: 100%
User data
    • nt06210 ERK signaling
      • N00252 Amplified ERBB2 to RAS-ERK signaling pathway
      • N00020 Amplified FGFR to RAS-ERK signaling pathway
      • N00259 Amplified MET to RAS-ERK signaling pathway
      • N00012 Mutation-activated KRAS/NRAS to ERK signaling pathway
    • nt06214 PI3K signaling
      • N00253 Amplified ERBB2 to PI3K signaling pathway
      • N00038 Amplified FGFR to PI3K signaling pathway
      • N00260 Amplified MET to PI3K signaling pathway
    • nt06215 WNT signaling
      • N00057 Mutation-inactivated APC to Wnt signaling pathway
      • N00257 Loss of CDH1 to beta-catenin signaling pathway
      • N00258 Mutation-inactivated CDH1 to beta-catenin signaling pathway
    • nt06218 TGFB signaling
      • N00256 TGFBR1-reduced expression to TGF-beta signaling pathway
    • nt06230 Cell cycle G1/S
      • N00254 CDKN1B-reduced expression to p27-cell cycle G1/S
      • N00255 Amplified CCNE to cell cycle G1/S
    • nt06232 Telomerase activity
      • N00240 TERT-overexpression to telomerase activity
    • nt06240 Transcription
      • N00115 Mutation-inactivated TP53 to transcription
      • N00250 CDX2-overexpression to transcriptional activation
      • N00251 CDX2-overexpression to transcriptional repression